Ambaru Ojia Jacinta
ID:
|
PREVALENCE OF SEPSIS, 30 DAY CASE FATALITY RATIO, AND OPTIMAL MORTALITY RISK SCORES AMONG POST-CHEMOTHERAPY CANCER PATIENTS WITH INFECTION AT ONCOLOGY CLINIC MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS3111ES
Aim 3. To determine the optimal mortality risk score to predict 30-day mortality for post cancer-chemotherapy patients with infection at oncology clinic Mbarara regional referral hospital,Aim 2. To determine the 30-day case fatality ratio for post-cancer chemotherapy patients with infection at oncology clinic Mbarara regional referral hospital ,Aim 1: To determine the point prevalence of sepsis in post-cancer chemotherapy patients with infection, according to mortality risk scores (qSOFA, UVA, SIRS), at Mbarara regional referral hospital ,To determine the prevalence of sepsis, 30-day case fatality ratio and optimal mortality risk score, among patients with post-cancer chemotherapy infection at oncology clinic MRRH,
|
Uganda |
2023-09-26 12:11:47 |
2026-09-26 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
MARTIN CHEBET
ID: UNCST-2021-R013905
|
THE INCIDENCE AND AETIOLOGY OF STILLBIRTHS IN EASTERN UGANDA
REFNo: HS3112ES
3. To assess the acceptability of minimal invasive autopsy in Eastern Uganda,2. To determine the infections associated with stillbirths in a regional referral hospital in eastern Uganda,1. To determine the incidence of and risk factors for stillbirths in a cluster-randomised trial cohort of pregnant women (the BabyGel trial) ,
|
Uganda |
2023-09-26 12:04:01 |
2026-09-26 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
.jpg)
|
Hellen Tabea
ID:
|
THE EXPERIENCE OF CONSECRATED PERSONS ON GRIEF AND COPING UPON THE LOSS OF A /RELIGIOUS/FAMILY MEMBER- UGANDA
REFNo: SS1927ES
To assess the religious and cultural factors influencing consecrated persons when faced with loss.,To find out how consecrated persons manage socio and economic factors to handle medical, psychological and moral issues in grief and loss.,To examine how consecrated member grief and mechanics of coping with loss of a member/family,To asses the experience of the consecrated persons in Uganda upon the less of a religious or family member.,
|
Uganda |
2023-09-26 11:59:11 |
2026-09-26 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Florence Asiimwe Munyonyo
ID:
|
A Phenomenological Study of Lived Experiences of Returnee Ugandan Migrant Domestic Workers from Saudi Arabia
REFNo: SS1905ES
4. To inform policy reforms for regulating the sector to maximize the benefits for the development of all stakeholders.,3. To examine how the lived experiences affected the realization of the goals for seeking employment in Saudi Arabia. ,2. To evaluate the lived experiences of returnee Ugandan migrant domestic workers before, during and when they return from Saudi Arabia. ,To examine the push and pull factors why returnee Ugandan migrant domestic workers seek employment in Saudi Arabia,
|
Uganda |
2023-09-26 11:56:57 |
2026-09-26 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Adoke Yeka
ID: UNCST-2021-R004300
|
PLATINUM: A multi-part, multi-center PLATform study to assess the efficacy, safety, tolerability and pharmacokinetics of anti-malarial agents administered as monotherapy at multiple dose levels and/or combination therapy IN patients with Uncomplicated Plasmodium falciparum Malaria.
REFNo: HS2817ES
Part A: To assess the parasite clearance time (PCT) of oral doses of an anti- malarial agent administered as monotherapy in patients with uncomplicated
P. falciparum malaria
Part B: To assess the effect on adjusted 28-day cure rate of an anti-malarial agent administered orally as combination therapy versus the standard of care (SoC) in patients with uncomplicated P. falciparum malaria.
Part A: To assess the effect on adjusted 28-day cure rate of an anti-malarial agent administered orally as monotherapy in patients with uncomplicated
P. falciparum malaria
Part B: To assess the parasite clearance time (PCT) of oral combinations of anti-malarial agents versus SoC in patients with uncomplicated P. falciparum malaria
All parts:
To characterize PK of each anti-malarial agent administered orally as monotherapy [Part A] and/or as combination therapy [Part B] in patients with uncomplicated P. falciparum malaria
To assess the safety and tolerability of each anti-malarial agent administered orally as monotherapy [Part A] and/or as combination therapy versus SoC [Part B] in patients with uncomplicated P. falciparum malaria
|
Uganda |
2023-09-26 11:55:15 |
2026-09-26 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|